Status:
UNKNOWN
Development of a Diagnostic Kit for FLT3-ITD in Acute Myeloid Leukemia
Lead Sponsor:
Taipei Medical University WanFang Hospital
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
Brief Summary
FLT3 overexpression in acute myeloid leukemia (AML) is often caused by mutations in this gene. These mutations cause constitutive phosphorylation of FLT3 proteins leading to increased proliferation an...
Eligibility Criteria
Inclusion
- Patients with confirmed diagnosis of acute myeloid leukemia
Exclusion
- non
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2011
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01141673
Start Date
June 1 2010
End Date
June 1 2011
Last Update
April 26 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University - WanFang Hospital
Taipei, Taiwan